138 related articles for article (PubMed ID: 33108201)
1.
Song L; Song M; Rabkin CS; Williams S; Chung Y; Van Duine J; Liao LM; Karthikeyan K; Gao W; Park JG; Tang Y; Lissowska J; Qiu J; LaBaer J; Camargo MC
J Proteome Res; 2021 Jan; 20(1):409-419. PubMed ID: 33108201
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of
Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
[TBL] [Abstract][Full Text] [Related]
3. Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia.
Song L; Song M; Rabkin CS; Chung Y; Williams S; Torres J; Corvalan AH; Gonzalez R; Bellolio E; Shome M; LaBaer J; Qiu J; Camargo MC
J Gastroenterol; 2023 Feb; 58(2):112-124. PubMed ID: 36301365
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
[TBL] [Abstract][Full Text] [Related]
5. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
[TBL] [Abstract][Full Text] [Related]
6. Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis.
El Hafa F; Wang T; Ndifor VM; Jin G
Helicobacter; 2022 Jun; 27(3):e12881. PubMed ID: 35212073
[TBL] [Abstract][Full Text] [Related]
7. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
10. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.
Fernández-de-Larrea N; Michel A; Romero B; Butt J; Pawlita M; Pérez-Gómez B; Castaño-Vinyals G; Moreno V; Martín V; Amiano P; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Clofent J; Alguacil J; Huerta JM; Jiménez-Moleón JJ; Barricarte A; Molinuevo A; Fernández-Villa T; Casabonne D; Sierra Á; Kogevinas M; de Sanjosé S; Pollán M; Del Campo R; Waterboer T; Aragonés N
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28737284
[TBL] [Abstract][Full Text] [Related]
11. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.
Maeda S; Yoshida H; Ogura K; Yamaji Y; Ikenoue T; Mitsushima T; Tagawa H; Kawaguchi R; Mori K; Mafune Ki; Kawabe T; Shiratori Y; Omata M
Cancer; 2000 Apr; 88(7):1530-5. PubMed ID: 10738209
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
13. Association between Helicobacter pylori VacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of VacA.
Ayala G; Torres-Mena J; López-Carrillo L
J Med Microbiol; 2008 Jan; 57(Pt 1):9-14. PubMed ID: 18065661
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.
Pan KF; Formichella L; Zhang L; Zhang Y; Ma JL; Li ZX; Liu C; Wang YM; Goettner G; Ulm K; Classen M; You WC; Gerhard M
Int J Cancer; 2014 May; 134(9):2118-25. PubMed ID: 24155048
[TBL] [Abstract][Full Text] [Related]
15. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
[TBL] [Abstract][Full Text] [Related]
17. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
20. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
